Gilead Sciences’ (GILD) new HIV prevention shot, lenacapavir, hit it out of the park in a…
-
-
In this edition of StockCharts TV‘s The Final Bar, Dave recaps a day where technology shares struggles, with…
-
Editor’s Note: This article was originally published on November 21, 2022. This article has absolutely nothing…
-
Moving averages are a crucial charting tool, but many of us aren’t getting the most out…
-
Who would have thought a mid-week break would halt the stock market’s winning streak? Maybe the…
-
In this edition of StockCharts TV‘s The Final Bar, Dave answers viewer questions on using technical indicators on…
-
Last week, the broader market Indices hit another new high on Thursday before pulling back into…
-
In this StockCharts TV video, Mary Ellen reviews the broader markets, takes a close look at NVDA…
-
Note to the reader: This is the twenty-fifth and final in .
-
The Dow Jones Industrial Average ($INDU) may not be the comprehensive measure of the US economy…